FDA NDC Directory · JSON-LD · Markdown

Victoza

NDC 0169-4060 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameliraglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA022341
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20100125
Package count4

External sources

Source: openFDA. Public-domain (CC0).